Impact Biomedical Inc. completes reverse stock split
- Reverse stock split ratio of 1-for-12.62
- Effective September 23, 2026
- Shares reduced from 107.8M to 8.6M
IBO
IMPACT BIOMEDICAL INC. SEC filings
Every EDGAR filing for IMPACT BIOMEDICAL INC. (IBO), newest first, with AI summaries and stories.
- Ticker
- IBO
- CIK
- 1834105
- Sector
- Biotech and pharma
- Latest filing
- Oct 9
Next: 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 3 open-market sales ($2K).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KIMPACT BIOMEDICAL INC.IBOLIVE ROUTINE4IMPACT BIOMEDICAL INC.IBOLIVE DSS, INC., insider filing for IBO
DSS, INC., reporting
NOTABLE10-QIMPACT BIOMEDICAL INC.IBOLIVE NOTABLE10-QIMPACT BIOMEDICAL INC.IBOLIVE ROUTINE144IMPACT BIOMEDICAL INC.IBOLIVE DSS, INC., planned sale of IBO shares
DSS, INC., reporting
ROUTINES-8 POSIMPACT BIOMEDICAL INC.IBOLIVE ROUTINES-8 POSIMPACT BIOMEDICAL INC.IBOLIVE ROUTINE4IMPACT BIOMEDICAL INC.IBOLIVE Todd D Macko, insider filing for IBO
Todd D Macko, reporting
ROUTINE4IMPACT BIOMEDICAL INC.IBOLIVE Jason Grady, insider filing for IBO
Jason Grady, reporting
NOTABLE10-KIMPACT BIOMEDICAL INC.IBOLIVE ROUTINE8-KIMPACT BIOMEDICAL INC.IBOLIVE ROUTINE4IMPACT BIOMEDICAL INC.IBOLIVE DSS, INC., insider filing for IBO
DSS, INC., reporting
ROUTINEDEF 14CIMPACT BIOMEDICAL INC.IBOLIVE ROUTINEPRE 14CIMPACT BIOMEDICAL INC.IBOLIVE NOTABLE10-QIMPACT BIOMEDICAL INC.IBOLIVE ROUTINE8-KIMPACT BIOMEDICAL INC.IBOLIVE